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Abstract
Aim—To investigate whether presumed
ocular histoplasmosis syndrome in the
Netherlands is caused by Histoplasma
capsulatum and whether other risk fac-
tors might play a role in the pathogenesis
of this syndrome.
Methods—23 patients were clinically diag-
nosed as having presumed ocular histo-
plasmosis syndrome based on the
following criteria: peripapillary atrophy,
punched out lesions, a macular disciform
lesion or scar in one eye without vitritis.
As controls, 66 sex and age matched
healthy volunteers were used. Serum
samples from both patients and controls
were tested for the presence of antibodies
against H capsulatum, Toxoplasma gon-
dii, Toxocara canis et cati, Ascaris sp, and
for the presence of antigens of Cryptococ-
cus neoformans. Serum samples were
also tested for the presence of autoanti-
bodies against retinal or choroidal pro-
teins. To investigate other risk factors,
patients and controls were asked to fill in a
health and travel related questionnaire.
Ten patients with ocular toxoplasmosis
were used as a disease control group.
Results—None of the patients with pre-
sumed ocular histoplasmosis syndrome or
controls had circulating antibodies di-
rected against H capsulatum. No risk fac-
tors could be identified and no indications
for autoimmunity and no evidence for the
role of the other infectious agents could be
demonstrated.
Conclusions—In a Dutch group of pa-
tients fulfilling the criteria of a disease
currently named presumed ocular histo-
plasmosis syndrome, no risk factors or
relation with the fungus H capsulatum
could be detected.
(Br J Ophthalmol 1999;83:535–539)
Presumed ocular histoplasmosis is a distinct
syndrome characterised by a macular disci-
form lesion or scar caused by choroidal
neovascularisation, peripapillary and chorio-
retinal scarring, and multiple, often sharply
circumscribed white atrophic scars (punched
out lesions) in combination with a clear
vitreous1 (Fig 1A and B). This syndrome is
mainly seen in the midwest of the United
States and is thought to be caused by
Histoplasma capsulatum, endemic in this area.2
In Europe a clinically similar syndrome has
been observed in areas where the infectious
agent H capsulatum is absent.3 4
The direct role of H capsulatum in the patho-
genesis of presumed ocular histoplasmosis has
not been clearly demonstrated, hence the
prefix “presumed”. This ocular syndrome is
likely to be immunologically mediated.5 How-
ever, serologically there has been no confirma-
tion of a direct correlation between Histoplasma
infection and ocular histoplasmosis even in
endemic areas.6 The relation has been based on
epidemiological studies.7 8 In European pa-
tients the direct contact with this infectious
agent preceding the ocular symptoms is
unlikely, unless the patient has lived or
travelled to endemic areas before the start of
ocular symptoms. It is possible that H capsula-
tum does not play a role in this syndrome and
that other risk factors are more important in
the aetiology of presumed ocular histoplasmo-
sis syndrome. This study was undertaken to
investigate possible risk factors associated with
the ocular syndrome presenting as ocular
histoplasmosis in the Netherlands.
Patients and methods
PATIENTS
In this study, patients were included who had
been clinically diagnosed in the ophthalmo-
logical departments of the university hospitals
Figure 1 (A) Left eye with peripapillary atrophy,
peripapillary punched out lesions. (B) Right eye with
disciform macular lesion.
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of Utrecht and Amsterdam as suVering from
presumed ocular histoplasmosis. Only patients
with both fundus photography and data
concerning the ophthalmic examination and
therapy were included. All patients had to
exhibit a macular disciform lesion or scar
caused by a choroidal neovascularisation, peri-
papillary and chorioretinal scarring, and multi-
ple, often sharply circumscribed white atrophic
scars (punched out lesions) in combination
with a clear vitreous.1
Fundus photographs were judged by an
experienced ophthalmologist (MdS) in a
masked fashion; fundus photographs from
patients were mixed in a file with fundus pho-
tographs of patients with other macular
disciform lesions. Patients were included in the
study when the fundus pictures were judged as
typical as described above.
From the patients who were diagnosed as
having presumed ocular histoplasmosis syn-
drome, a serum sample was obtained and
stored at the serum bank at the Netherlands
Ophthalmic Research Institute.
Patients who were immunocompromised, or
who suVered from any ocular disease that may
mimic this syndrome, such as high myopia, age
related macular degeneration, and other white
dot syndromes were excluded from this study.
CONTROLS
Two control groups were used: group I
consisted of 66 sex and age matched healthy
volunteers; group II contained 10 patients
diagnosed as having a toxoplasma chorioretini-
tis by means of clinical diagnosis which had
been confirmed by intraocular antibody pro-
duction against Toxoplasma gondii (and in five
of these 10 cases also DNA of T gondii was
detected by polymerase chain reaction (PCR)).
All subjects included in the study gave their
informed consent to participate in this study.
METHODS
All patients and all healthy controls answered a
detailed questionnaire. Questions were asked
about travel to areas endemic for H capsulatum;
possible contacts with infectious agents, use of
untreated or poorly treated drinking water and
swimming in endemic areas; contacts with pets
or professional animal contacts; contact with
soil and sand; eating habits particularly the
consumption of raw meat, or the frequency of
barbecuing. In addition, a medical history
regarding systemic infectious diseases and pre-
vious blood transfusions was recorded.
LABORATORY TESTS
To exclude H capsulatum as a possible causative
agent in our patients suVering from presumed
ocular histoplasmosis, antibodies against this
fungus were measured. Antibodies against
Toxoplasma gondii, Ascaris sp, Toxocara canis et
cati were tested since these parasites can also
give symptoms of inflammation of the poste-
rior segment. In order to exclude the presence
of any other fungal infection, antigens of Cryp-
tococcus neoformans were tested, since this
fungus is also present in Europe. Antibodies
against Candida sp were not tested, as Candida
sp is endemic in this region and all sera were
expected to be positive. Sera were not tested
for antibodies against Blastomyces and Coccidi-
oides because both these fungi are not present
in Europe and no positive serology has been
described in European patients.
The presence of antibodies against H capsu-
latum was tested by immunodiVusion (Fungal
immunodiVusion system, Meridian diagnos-
tics, Inc, OH, USA) following the manufactur-
er’s protocol.9 ImmunodiVusion is highly
specific for the detection of antibodies directed
against H capsulatum.10 As a positive control,
serum from a patient with an active systemic
histoplasmosis was used (courtesy of Dr
Wheat, Indianapolis, IN, USA).
The presence of Cryptococcus neoformans
antigens was tested by a latex agglutination test
(Crypto-LA test, Whampoule Laboratories,
International Biological Labs, Inc, Cranbury,
USA) according to the manufacturer’s instruc-
tions.
The presence of antibodies to T gondii was
tested in a 1:20 dilution and the presence of
antibodies directed to Toxocara cani et cati and
Ascaris sp was tested in a 1:40 dilution. These
antibodies were measured by an in house
enzyme linked immunosorbent assay at the
Diagnostic Laboratory for Infectious Diseases
and Perinatal Screening, National Institute
of Public Health and the Environment,
Bilthoven, Netherlands. Tests were considered
positive when the respective dilutions showed a
signal.
To exclude a possible autoimmune compo-
nent we also tested for the presence of autoan-
tibodies against retinal or choroidal proteins.
Retina and choroid were retrieved from human
donor eyes. Total protein extracts were ob-
tained by dissolving retina or choroid tissue in
SDS-PAGE loading buVer containing 2% SDS
and 5% â-mercapto-ethanol followed by boil-
ing for 5 minutes. After centrifugation, the
proteins were size fractioned by SDS-PAGE
gel electrophoresis and followed by western
blotting. Blots were incubated with a 1:50 dilu-
tion of sera from patients and controls. After 1
hour incubation, blots were washed and
incubated with peroxidase labelled rabbit anti-
human immunoglobulins (Dako) for 1 hour.
Blots were stained with diaminobenzidine
tetrahydrochloride (Sigma-Aldrich Chemie,
Zwijndrecht, Netherlands) and photographed
directly after the reaction was stopped. Sera
that gave bands other than the control sera
were considered positive.
To further investigate the presence of
autoantibodies, cryosections of rat eyes were
incubated with sera of 13 patients with
presumed ocular histoplasmosis in a 1:100
dilution for 2 hours. After washing one
cryosection was incubated with peroxidase
labelled rabbit anti-human immunoglobulins
and one with peroxidase labelled rabbit anti-
human IgG. The cryosections were stained
with diaminobenzidine tetrahydrochloride.
Cryosections were independently judged by
two observers. As a negative control a sample
of pooled normal human sera was used, and as
a positive control a serum sample was used
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known to have antibodies against retinal
antigens.
STATISTICS
Data were evaluated by the Student’s t test,
Fisher’s exact probability test or ÷2 test.
Results
Twenty three patients with presumed ocular his-
toplasmosis syndrome were selected (median
age 35 years; range 28–60), seven men (median
age 33 years; range 28–48) and 16 women
(median age 40 years; range 29–60). The mean
age at the onset of symptoms was 30 years.
Blood samples were collected in the course of
the disease with a mean of 8 years after the start
of symptoms, 15 of those samples were taken
within 10 years after the onset of disease and
eight within 5 years (Table 1).
As healthy controls, we used 17 men (median
age 36 years, range 26–44) and 49 women
(median age 42 years, range 26–60), from whom
a venous blood sample was collected at the time
the questionnaire was completed. Ten patients
with toxoplasma chorioretinitis (mean age 50,
range 29–65), three men and seven women,
confirmed by detection of intraocular anti-
Toxoplasma IgG production, were used as
disease controls in the serological tests.
LABORATORY TEST RESULTS
Testing for H capsulatum antibodies was nega-
tive in all people tested, both in patients and in
controls (Table 2). The serum of the positive
control, from a patient with systemic histoplas-
mosis, showed H and M bands in the immuno-
diVusion test (Fig 2).
All sera of patients and controls were
negative for C neoformans antigens.
Thirteen of 23 patients (57%) with presumed
ocular histoplasmosis syndrome were positive
for IgG antibodies against T gondii compared
with 42 of 66 healthy controls (64%). This was
not significantly diVerent (p >0.01).
IgG antibodies to Toxocara canis et cati were
positive in two out of 23 patients with
presumed ocular histoplasmosis syndrome
compared with four out of 66 healthy controls
and three out of 10 patients with toxoplasma
chorioretinitis (p >0.01).
Six of 23 patients with presumed ocular his-
toplasmosis syndrome had IgG antibodies to
Ascaris sp in their serum. Twenty two out of 66
controls (33%) had IgG antibodies, and eight
of 10 patients (80%) with toxoplasma chorio-
retinitis. The patients with toxoplasma chorio-
retinitis had antibodies against Ascaris sp
significantly more often than the healthy
controls and patients with presumed ocular
histoplasmosis (p <0.01).
Sera from 23 patients and 20 healthy
controls were tested for the presence of retinal
or choroidal autoantibodies by western blot-
ting. Eight patients had chorioretinal autoanti-
bodies compared with five of the healthy
controls. No distinctive banding pattern was
seen between the two groups.
Analysis of chorioretinal autoantibodies
using immunohistochemistry on cryosections
did not reveal a positive staining in the patients
tested.
RESULTS FROM THE QUESTIONNAIRE
Twenty two of 23 (95%) patients returned the
questionnaire and all controls of group I
(healthy volunteers). Only six out of 22 (27%)
patients had lived or travelled to areas endemic
for H capsulatum before the onset of their ocu-
lar symptoms compared with 38 out of 66
Figure 2 ImmunodiVusion test for antibodies against H capsulatum. Left: positive control
serum, showing H and M bands. Wells 1 and 4 positive serum provided with the kit, wells 2
and 5 serum from a patient positive for antibodies against H capsulatum, wells 3 and 6
serum from a patient negative for antibodies against H capsulatum. Well 7 Histoplasmin.
Right: two negative sera. Wells 1 and 4 positive serum provided with the kit, wells 2, 3, 5,
and 6 serum from two patients negative for antibodies against H capsulatum. Well 7
Histoplasmin.
Table 1 Participant charactristics
Patients (n=23) Controls (n=66) Disease controls (n=10)
Median age (years)
Female 40 (range 29–60) 42 (range 26–60) 46 (range 29–55)
Male 33 (range 28–48) 36 (range 26–44) 53 (range 36–65)
Mean age at start of symptoms (years) 30 (SD 6.5) (range 18–44)
Time interval between start of symptoms
and sample collection (years) 8 (SD 6.7) (range 0.5–23)
Sex 16 F/7 M 49 F/17 M 7 F/3 M
Table 2 Results of tests to detect antibodies
H capsulatum C neoformans* T gondii Toxocara sp Ascaris sp
Patients with presumed ocular histoplasmosis
syndrome (n=23) 0 (0%)† 0 (0%)‡ 13 (57%) 2 (8%) 6 (26%)
Controls (n=66) 0 (0%) 0 (0%) 42 (64%) 4 (6%) 22 (33%)
Controls with toxoplasma chorioretinitis (n=10) 0 (0%) 0 (0%) 10 (100%) 2 (20%) 8 (80%)
*Sera were tested for the presence of antigens of C neoformans.
†The positive control serum used showed only the presence of antibodies against H capsulatum and was negative in all other tests.
‡The positive control was included in the kit.
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(57%) controls before obtaining the blood
sample.
Animal contact was not significantly diVer-
ent between patients and controls. No diVer-
ence could be demonstrated when comparing
patients and controls who gardened with or
without gloves.
In both groups, one participant was vegetar-
ian, and no diVerence could be found in the
frequency of barbecuing or eating “raw” meat.
None of the patients, nor any controls, had
had therapy for infection with herpes viruses,
T gondii, H capsulatum, or Cryptococcus neo-
formans.
One of the patients and eight of the controls
remembered having had contact with Ascaris
sp or being treated with mebendazole for an
infection with Ascaris sp; this was not statisti-
cally significant.
Three of 22 patients had a blood transfusion
some time before the onset of ocular symp-
toms, as did six of 66 controls. One of the
patients and also one of the controls had
suVered from gonorrhoea in the past.
Eight out of 22 patients did mention a
period of stress around the onset of ocular
symptoms, compared with 11 of 66 controls
during a similar period before blood sampling.
This seemed statistically significant (p=0.05).
Patients indicated the start of a new job, mov-
ing to another town or pregnancy among stress
factors.
Discussion
In Europe, an ocular syndrome identical to
that called presumed ocular histoplasmosis
syndrome in the USA has been described,3 4
while H capsulatum is not endemic in this area.
Several studies support an association between
H capsulatum infection and the classic ocular
triad of presumed ocular histoplasmosis in
humans. This association is mainly based on
epidemiological data from endemic areas7 8
and animal models, in which H capsulatum was
injected into the carotid artery of primates
which developed atypical choroidal lesions 4
weeks after inoculation.11 There are no reports
of positive H capsulatum cultures in patients
with presumed ocular histoplasmosis syn-
drome, but H capsulatum has been cultured
from a patient with postoperative
endophthalmitis.12 In another report, two
immunocompetent patients with systemic his-
toplasmosis (confirmed by antibodies in serum
as well as in urine) showed choroiditis, but no
intraocular fluid analysis was performed.13 In
these two patients the clinical picture did not
show the complete typical clinical characteris-
tics of presumed ocular histoplasmosis
syndrome.13 Furthermore, one would expect
that opportunistic ocular infections should be
more frequently seen in immunocompromised
patients, as up to 16% of these patients have a
disseminated infection by H capsulatum in
endemic areas.14 In the literature, however,
positive cultures from ocular fluid samples
obtained from patients with AIDS are de-
scribed only twice. In these two patients the
clinical picture did not resemble the typical
clinical characteristics of presumed ocular his-
toplasmosis syndrome.15 16
Serologically there has been no confirmation
of a direct link between infection with H capsu-
latum and presumed ocular histoplasmosis
syndrome, even in endemic areas. In his-
topathological studies of eyes from patients
with presumed ocular histoplasmosis syn-
drome no direct correlation could be demon-
strated by immunohistochemical staining.17 In
surgically removed membranes of patients suf-
fering from presumed ocular histoplasmosis no
fungi could be detected by electron micros-
copy and only non-specific inflammatory reac-
tion tissue could be shown.18 Therefore, the
ocular changes might be late immunological
reactions to a previous infection with H capsu-
latum, or H capsulatum does not play a role at
all in this syndrome.7 19
In our study, no risk factors could be identi-
fied through our questionnaire that might have
played a role in the pathogenesis of presumed
ocular histoplasmosis syndrome. Careful as-
sessment of travelling, eating habits, and
animal contacts did not reveal any shared pos-
sible infectious risks.
None of our patients with presumed ocular
histoplasmosis syndrome showed serological
evidence of previous contact with H capsula-
tum, as was also the case in the group of healthy
controls and disease controls. It is generally
assumed that the manifestations of presumed
ocular histoplasmosis syndrome is a late
sequela of a previous infection with H capsula-
tum and that the interval between the primary
infection and the first ocular symptoms might
take many years.20 IgG antibodies against H
capsulatum persist for years after an acute
infection.21 Therefore, at least some of our
patients with this ocular syndrome should have
shown serological evidence of previous con-
tact. Skin testing was not performed because of
described reactivation of the ocular lesions in
patients with macular disease.22
It was possible to exclude as a causative
mechanism other infectious agents that are
present in Europe and that might induce
chorioretinopathy, such as C neoformans, T
gondii, Toxocara sp, and Ascaris sp. Of these, the
first was negative in all people, while antibodies
to the others were evenly distributed in all
groups. When the group of patients with ocular
toxoplasmosis (eight out of 10 had antibodies
against Ascaris sp) was compared with the con-
trols (22 out of 66 had antibodies against
Ascaris sp), this diVerence seemed statistically
significant (p <0.01). But when the eight
patients with ocular toxoplasmosis and positive
serology against Ascaris sp were compared with
the 19 controls who had antibodies against
Toxoplasma gondii as well as antibodies against
Ascaris sp the diVerence was not significant (p=
0.2). This might be due to similar risk factors
shared by both groups for infection with T gon-
dii and Ascaris sp.
Autoimmunity might also play an aetiologi-
cal role in this syndrome. There have been
reports of a relation with HLA-DRw2 or
HLA-B7, showing a higher frequency in these
patients with disciform lesions compared with
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healthy people.23 24 Racial diVerences might
also play a role as this ocular disease occurs
predominantly in white females. This is in
accordance with our results, which included
only white Europeans.25 Nevertheless, no clear
evidence was found by western blotting and
immunohistochemistry to suggest that the
ocular syndrome might be the result of autoan-
tibodies against choroid or retina.
In conclusion, no risk factors and no relation
with the fungus H capsulatum could be
detected. We therefore suggest that this ocular
syndrome in patients from non-endemic areas
should no longer be called presumed ocular
histoplasmosis. The cause in our patients is
probably multifactorial and might depend, as
in other white dot syndromes, on interactions
between triggering factors involved in presen-
tation of antigens and the host immune
system.26 Subsequent inflammation around
choriocapillary dendritic cells can lead to scars
seen in several white dot syndromes.26 There-
fore, in European patients, it might be better to
use as basis for the nomenclature not the aeti-
ology but the clinical and histopathological
presentation. Even in the United States pre-
sumed ocular histoplasmosis syndrome might
be a misnomer; “multifocal choroidopathy” is,
in our opinion, a more appropriate description.
We thank Dr L J Wheat from the Wishard Memorial Hospital,
Indianapolis, Indiana, USA, for providing us with the serum of
a patient with systemic histoplasmosis.
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